Brief: Invion Ltd Says Funding Agreements Cover Up To 85% Of Clinical Trials Costs
Wed 02:21
BRIEF-Invion Ltd Says Funding Agreements Cover Up To 85% Of Clinical Trials Costs Oct 21 (Reuters) - Invion Ltd IVX.AX:
FUNDING AGREEMENTS COVER UP TO 85% OF CLINICAL TRIALS COSTS
POINT8 CAPITAL AND ROCKFORD CAPITAL TO COVER UP TO 85% OF INVION CLINICAL TRIAL COSTS
Further company coverage: IVX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Invion
See all newsAustralia's Invion rises after securing clinical trial funding arrangements
Brief: Invion Ltd Says Funding Agreements Cover Up To 85% Of Clinical Trials Costs
Brief: Invion Announces Preclinical Research Collaboration With Percheron Therapeutics
Australia's Invion enters ophthalmology agreement with Sangmyung Innovation
Brief: Invion Signs First Ophthalmology Collaboration Agreement With Sangmyung Innovation